Antimicrobial peptide LL-37 increases rhinovirus-induced interferon β expression in human airway epithelial cells through a Ca2+-dependent mechanism
Open Access
- 21 June 2025
- journal article
- Published by Elsevier in Biochemistry and Biophysics Reports
- Vol. 43, 102105
Abstract
No abstract availableKeywords
Funding Information
- Gyllenstiernska Krapperupsstiftelsen (KR2024-0001)
- Swedish Research Council (2020-00922)
- Swedish Research Council (2023-02030)
- Alfred Österlunds Foundation
- Heart and Lung Foundation (20210440)
- Heart and Lung Foundation (20230255)
This publication has 39 references indexed in Scilit:
- Human host defense peptide LL-37 facilitates double-stranded RNA pro-inflammatory signaling through up-regulation of TLR3 expression in vascular smooth muscle cellsInflammation Research, 2020
- Antimicrobial Peptide LL37 and MAVS Signaling Drive Interferon-β Production by Epidermal Keratinocytes during Skin InjuryImmunity, 2016
- Gingival crevicular fluid and serum hCAP18/LL-37 levels in generalized aggressive periodontitisClinical Oral Investigations, 2016
- On the Dependency of Cellular Protein Levels on mRNA AbundanceCell, 2016
- Host defense peptides: front-line immunomodulatorsTrends in Immunology, 2014
- LL-37: An Immunomodulatory Antimicrobial Host Defence Peptide2012
- Induction and function of type I and III interferon in response to viral infectionCurrent Opinion in Virology, 2011
- Human rhinoviruses: The cold wars resumeJournal of Clinical Virology, 2008
- The role of rhinovirus in asthma exacerbationsJournal of Allergy and Clinical Immunology, 2005
- Evaluation of the Inactivation of Infectious Herpes Simplex Virus by Host-Defense PeptidesEuropean Journal of Clinical Microbiology & Infectious Diseases, 2000